Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;35(3):503-13.
doi: 10.1007/s11064-009-0087-5. Epub 2009 Nov 11.

Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer's Disease

Affiliations

Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer's Disease

Thomas Fraser et al. Neurochem Res. .

Abstract

Dietary omega3-polyunsaturated fatty acids are thought to influence the risk of Alzheimer's disease (AD), and supplemental docosahexaenoic acid (DHA; 22:6n-3) has been reported to reduce neurodegeneration in mouse models of AD. We have analysed the fatty acid composition of frontal, temporal and parietal neocortex in 58 normal and 114 AD brains. Significant reductions were found for stearic acid (18:0) in frontal and temporal cortex and arachidonic acid (20:4n-6) in temporal cortex in AD, and increases in oleic acid in frontal and temporal cortex (18:1n-9) and palmitic acid (16:0) in parietal cortex. DHA level varied more in AD than controls but the mean values were not significantly different. Fatty acid composition was not related to APOE genotype, age, gender or post-mortem delay. Further research is needed to distinguish between alterations that are secondary to AD and those that contribute to the disease process.

Similar articles

See all similar articles

Cited by 43 articles

See all "Cited by" articles

References

    1. Int J Vitam Nutr Res. 2000 Sep;70(5):251-9 - PubMed
    1. Neurobiol Dis. 2009 Mar;33(3):482-98 - PubMed
    1. Am J Clin Nutr. 2009 Jul;90(1):184-92 - PubMed
    1. J Neurochem. 2005 Nov;95(4):987-97 - PubMed
    1. Neurochem Res. 1998 Jan;23(1):81-8 - PubMed

Publication types

LinkOut - more resources

Feedback